This decline can lead to various health issues, including weakened immunity, increased oxidative stress, and diminished detoxification capacity
Now, Novo Nordisk says it has fixed those problems, and some doctors say their patients can get the medication
If something doesnt change, the next few years are going to focus on all the people who could benefit from GLP-1s but are unable to access them
Patients should never freeze tirzepatide or use medication that has been frozen, as this can alter its efficacy
Endocrinology 135 , 14881495 (1994)
By influencing these pathways, GLP-1s may reduce the rewarding feeling associated with certain foods